Both in Biotechnology
Jasper Therapeutics vs TScan Therapeutics
Over the past year JSPR returned −74.9% and TCRX returned −81.8%; their daily moves had a correlation of 0.11.
JSPR −74.9% TCRX −81.8%Growth of $1, one year, split-adjusted
| Metric | JSPR | TCRX |
|---|---|---|
| Price | $0.6254 | $0.3175 |
| Market cap | $20.8M | $21.5M |
| Today | −0.10% | −6.62% |
| 1 month | −10.6% | −57.9% |
| 6 months | −30.5% | −66.2% |
| Year to date | −65.8% | −68.3% |
| 1 year | −74.7% | −82.8% |
| Revenue growth (YoY) | — | −65.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −2888.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.0× |
| Net cash | $7.3M | $67.4M |
| Dividend yield | — | — |
| Volatility (60d) | 100.6% | 138.5% |
| Short % of float | 25.5% | 4.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).